TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
7.65
-2.06 (-21.22%)
At close: May 15, 2025, 4:00 PM
7.88
+0.23 (3.01%)
Pre-market: May 16, 2025, 8:43 AM EDT
TransCode Therapeutics Stock Forecast
RNAZ's stock price has decreased by -98.87% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for TransCode Therapeutics stock has a target of 280, which predicts a 3,560.13% increase from the current stock price of 7.65.
Price Target: $280.00 (+3,560.13%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 16, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for TransCode Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $560 → $280 | Strong Buy | Maintains | $560 → $280 | +3,560.13% | Apr 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $560 | Strong Buy | Reiterates | $560 | +7,220.26% | Mar 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $560 | Strong Buy | Reiterates | $560 | +7,220.26% | Feb 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $560 | Strong Buy | Reiterates | $560 | +7,220.26% | Feb 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $84 → $560 | Strong Buy | Maintains | $84 → $560 | +7,220.26% | Dec 18, 2024 |
Financial Forecast
Revenue This Year
n/a
from 28.36M
Revenue Next Year
n/a
EPS This Year
-4.46
from -1.32K
EPS Next Year
-0.33
from -4.46
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 525,000 | n/a | ||
| Avg | n/a | 510,000 | n/a | ||
| Low | n/a | 490,000 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -4.59 | -0.34 | -0.25 | ||
| Avg | -4.46 | -0.33 | -0.24 | ||
| Low | -4.28 | -0.31 | -0.24 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.